| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
14,570
|
19,153
|
26,154
| | Cost of Revenue | 4,309 | 4,555 | 7,104 | | |
Gross Profit
|
10,261
|
14,598
|
19,050
| |
|
Operating Expenses |
|
Research Development | 5,457 | 5,191 | 4,223 |
|
Selling General and Administrative | 34,545 | 27,686 | 34,840 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(29,741)
|
(18,279)
|
(20,013)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (147) | 6 | 486 |
|
Earnings Before Interest And Taxes | (29,888) | (18,273) | (19,527) |
|
Interest Expense |
-
|
-
|
-
|
|
Income Before Tax | (29,888) | (18,273) | (19,527) |
|
Income Tax Expense |
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (29,888) | (18,273) | (19,527) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(29,888)
|
(18,273)
|
(19,527)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(29,888)
|
(18,273)
|
(19,527)
|
|